📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The development of potent, competitive CXCR4 antagonists for the prevention of cancer metastasis. (2023)

First Author: Hamshaw I

Attributed to: New high resolution mass spectrometry facilities for macromolecules and metabolites at the University of East Anglia funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.bcp.2023.115921

PubMed Identifier: 37956893

Publication URI: http://europepmc.org/abstract/MED/37956893

Type: Journal Article/Review

Volume: 218

Parent Publication: Biochemical pharmacology

ISSN: 0006-2952